Skip to main content

Table 1 Characteristics and follow-up outcomes of 15 malignant musculoskeletal tumor patients

From: Use of extended curettage with osteotomy and fenestration followed by reconstruction with conservation of muscle insertion in the treatment of Enneking stage II locally aggressive bone tumor of the proximal extremities: resection and treatment of bone tumors

 

Gender

Age (years)

Site

Diagnosis

Treatment

Follow-up (months)

Recurrence (months after surgery)

Enneking score

Rating of score

 

F

22

PH

ABC

IC+BG

37

-

29

Very good

 

M

19

PF

ABC

IC+BG

47

-

29

Very good

 

M

22

PH

ABC

IC+BG

36

-

29

Very good

 

F

27

PF

ABC-R

IC+BG

72

9

20

Good

 

M

21

PF

ABC

IC+BG

35

-

28

Very good

 

F

28

PF

ABC-R

IC+BG

45

-

29

Very good

 

M

27

PF

CBT

IC+BG

52

-

29

Very good

 

M

37

PF

GCT

IC+BC

46

-

29

Very good

 

M

19

PH

CBT

IC+BG

54

-

29

Very good

 

F

33

PF

GCT

IC+BC

43

-

28

Very good

 

F

38

PF

GCT

IC+BC

66

12

18a

Moderatea

 

F

42

PH

GCT

IC+BC

53

-

29

Very good

 

M

38

PH

CBT

IC+BG

45

-

28

Very good

 

F

26

PH

ABC

IC+BG

25

-

19

Good

 

M

36

PF

GCT

IC+BC

67

-

29

Very good

Totals

M 8/15 (53%)

29 ±7.75 (18 to 42)b

PF: 6/15 (40%)

ABC: 7/15 (47%)c

IC+BC: 5/15 (33%)

48 ±12.95 (25 to 72)b

Two

27 ±4.07 (18 to 29)b

Very Good 12/15 (80%)

 

F 7/15 (47%)

 

PH: 9/15 (60%)

CBT: 3/15 (20%)

IC+BG: 10/15 (66%)

PH: 42 ±11.2 (25 to 67)b

 

PH: 27 ±4.3 (19 to 29)b

 
    

GCT: 5/15 (33%)

 

PF:53 ±12.7 (35 to 72)b

 

PF: 27 ±4.0 (18 to 29)b

 
  1. ABC, aneurysmal bone cyst; ABC-R, recurrent aneurysmal bone cyst; BC, bone cement augmentation; BG, bone grafting; CBT, chondroblastoma; F, female; GCT, giant-cell tumor of bone; IC, extended curettage; M, male; PH, proximal humerus; PF, proximal femur.
  2. aPostsurgical scores and ratings after recurrence prior to secondary surgery; bmean ±SD (range); ctwo recurrent cases.